ArticleJAMA network open2022

Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.

Hyung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.